Rebecca L. Olin, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
olin_rebecca

Assistant Professor, Department of Medicine (Hematology/Oncology), UCSF

Phone: (415) 353-2421 (appts)
Box 1270, UCSF
San Francisco, CA 94143-1270

View on UCSF Profiles


Additional Websites


Education

Amherst College, Amherst, MA, B.A., 1999, Biology
University of Pennsylvania School of Medicine, M.D., 2003
University of Pennsylvania, M.S., 2009, Clinical Epidemiology

Professional Experience

  • 2003-2006
    Internship and residency, Internal Medicine, University of Pennsylvania Hospital
  • 2006-2009
    Fellowship, Hematology/Oncology, University of Pennsylvania Hospital
  • 2007-2008
    Chief Fellow, Hematology/Oncology, University of Pennsylvania Hospital
  • 2009-present
    Assistant Clinical Professor of Medicine, University of California San Francisco

Honors & Awards

  • 1999
    Phi Beta Kappa, Amherst College
  • 2002
    Alpha Omega Alpha, early induction, University of Pennsylvania
  • 2002
    Botelho Prize for Excellence in Basic Science
  • 2003
    Dr. Spencer Morris Prize
  • 2005
    American Society of Hematology Trainee Award
  • 2008
    American Society of Hematology Travel Award

Selected Publications

  1. Keller JW, Andreadis C, Damon LE, Kaplan LD, Martin TG, Wolf JL, Ai WZ, Venstrom JM, Smith CC, Gaensler KM, Hwang J, Olin RL. Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients. J Geriatr Oncol. 2014 Jul; 5(3):238-44.
    View on PubMed
  2. Olin RL, Andreadis C. David versus Goliath: decision analysis predicts results of a large clinical trial in follicular lymphoma. J Clin Oncol. 2013 Oct 1; 31(28):3608-9.
    View on PubMed
  3. Olin RL, Kanetsky PA, Ten Have TR, Nasta SD, Schuster SJ, Andreadis C. Determinants of the optimal first-line therapy for follicular lymphoma: a decision analysis. Am J Hematol. 2010 Apr; 85(4):255-60.
    View on PubMed
  4. Olin RL, Vogl DT, Porter DL, Luger SM, Schuster SJ, Tsai DE, Siegel DL, Cook RJ, Mangan PA, Cunningham K, Stadtmauer EA. Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma. Bone Marrow Transplant. 2009 Mar; 43(5):417-22.
    View on PubMed
  5. Olin RL, Nichols KE, Naghashpour M, Wasik M, Shelly B, Stadtmauer EA, Vogl DT. Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis. Am J Hematol. 2008 Sep; 83(9):747-9.
    View on PubMed
  6. Olin RL, Desai SS, Fox K, Davidson R. Non-myopathic cardiac events in two patients treated with trastuzumab. Breast J. 2007 Mar-Apr; 13(2):211-2.
    View on PubMed

Go to UCSF Profiles, powered by CTSI